Search

Edwards Lifesciences Corp

Open

SectorGezondheidszorg

86.24 0.7

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

84.49

Max

87.04

Belangrijke statistieken

By Trading Economics

Inkomsten

-139M

241M

Verkoop

92M

1.7B

K/W

Sectorgemiddelde

52.583

55.725

EPS

0.78

Winstmarge

13.866

Werknemers

16,000

EBITDA

20M

520M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+20.61% upside

Dividenden

By Acuity

Volgende Winsten

29 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2B

51B

Vorige openingsprijs

85.54

Vorige sluitingsprijs

86.24

Nieuwssentiment

By Acuity

30%

70%

47 / 339 Rangschikking in Healthcare

Edwards Lifesciences Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

23 sep 2026, 20:02 UTC

Edwards Lifesciences Corp shares fell sharply, remaining well below their 20-day moving average and near the lower end of their one-month range.

22 sep 2026, 23:01 UTC

Edwards Lifesciences Corp is trading modestly higher in after-market hours, nearing the upper end of its one-month trading range.

17 sep 2026, 20:07 UTC

Edwards Lifesciences Corp shares fell sharply on Thursday, continuing a downward trend that began after Wednesday's close, despite peaking in the morning.

16 sep 2026, 23:41 UTC

Edwards Lifesciences Corp saw a modest decline in after-hours trading, continuing a downward trend that has intensified since Wednesday's close.

15 sep 2026, 20:51 UTC

Edwards Lifesciences shares are lower in after-market trading. Broader market sentiment is pressured by rising crude oil prices amid geopolitical tensions in the Middle East.

14 sep 2026, 20:08 UTC

Edwards Lifesciences Corp shares are higher during Monday's session, reflecting an upward trend since Friday's close, despite being below the 20-day moving average.

11 sep 2026, 20:02 UTC

News

Edwards Lifesciences shares are lower despite receiving an Overweight rating and a $101 price target from Piper Sandler amid mixed TAVR coverage sentiment.

8 sep 2026, 20:02 UTC

Correlated Moves

Edwards Lifesciences Corp is declining in Tuesday's session, mirroring broader losses in the medical devices sector and trading below its 20-day moving average.

2 sep 2026, 19:16 UTC

Shares of Edwards Lifesciences Corp. are lower today amid broader market pressures from rising bond yields, reflecting a routine trading pattern.

31 aug 2026, 19:56 UTC

News

Edwards Lifesciences Corp shares are higher today, continuing momentum from Friday. The broader health care equipment sector is also showing strength.

26 aug 2026, 19:56 UTC

Edwards Lifesciences is trading higher, despite a slight pullback from earlier session highs. The stock remains above its 20-day moving average.

24 aug 2026, 19:16 UTC

Edwards Lifesciences Corp shares are higher, continuing positive momentum since Friday's close, despite pulling back from an earlier session high.

20 aug 2026, 20:01 UTC

Edwards Lifesciences Corp shares are lower, driven by a decline in the Health Care Equipment sub-sector and ongoing market weakness since Wednesday's close.

19 aug 2026, 19:26 UTC

Edwards Lifesciences Corp shares are higher during Wednesday's trading session, showing notable volatility while remaining above their 20-day moving average.

18 aug 2026, 23:06 UTC

Edwards Lifesciences shares are lower in after-market hours amid rising U.S. bond yields, contributing to market concerns despite recent softer economic data.

13 aug 2026, 20:06 UTC

Edwards Lifesciences shares are lower today, tracking a broader market decline. The stock remains above its 20-day moving average and near its one-month range.

12 aug 2026, 22:16 UTC

Edwards Lifesciences shares declined in after-market trading, despite earlier fluctuations. The stock remains above its 20-day moving average and near its one-month range.

11 aug 2026, 19:21 UTC

Edwards Lifesciences Corp is trading higher, maintaining upward momentum after four consecutive daily gains and peaking in the late morning session.

10 aug 2026, 19:51 UTC

Edwards Lifesciences shares are higher today, reflecting unusual strength above the 20-day moving average amid uncertainty over the Federal Reserve's interest rate policy.

7 aug 2026, 19:16 UTC

Edwards Lifesciences Corp. shares are higher today, fluctuating within a routine range since Thursday's close, currently trading above its 20-day moving average.

5 aug 2026, 19:56 UTC

Edwards Lifesciences shares are lower today, continuing a decline since Tuesday. The stock remains above its 20-day moving average.

4 aug 2026, 19:36 UTC

Edwards Lifesciences shares are higher amid positive market momentum, despite a notable decline in U.S. core factory orders reflecting weakening demand across sectors.

3 aug 2026, 22:02 UTC

Edwards Lifesciences Corp shares are lower in after-market hours, following a notable decline that reached a session low shortly after the market opened.

31 jul 2026, 19:46 UTC

Edwards Lifesciences shares are lower, reflecting broader market trends amid inflation and interest rate concerns. The stock is trading below its 20-day moving average.

30 jul 2026, 22:06 UTC

Edwards Lifesciences shares are trading lower in after-market hours, reflecting ongoing weakness and uncertainty following the Federal Reserve's interest rate decision.

29 jul 2026, 23:46 UTC

Edwards Lifesciences Corp shares are higher in after-market trading, following four consecutive sessions of gains. No specific news was identified to explain the movement.

28 jul 2026, 18:46 UTC

News

UBS analyst Danielle Antalffy initiated coverage on Edwards Lifesciences with a Buy rating and $110 price target, boosting shares modestly higher today.

27 jul 2026, 19:41 UTC

Social Media
News

Edwards Lifesciences shares rise as TAVR revenue hits $35 million, driven by a 10.5% increase in U.S. sales, surpassing expectations.

24 jul 2026, 18:41 UTC

News

Edwards Lifesciences Corp is trading lower today despite positive analyst ratings. The stock pulled back from an earlier session high and has declined since Thursday's close.

23 jul 2026, 23:41 UTC

News
Event

Edwards Lifesciences reported Q2 sales of $1.74 billion, exceeding expectations. Shares are gaining in after-market hours following the results and raised guidance.

Peer Vergelijking

Prijswijziging

Edwards Lifesciences Corp Prognose

Koersdoel

By TipRanks

20.61% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 103.4 USD  20.61%

Hoogste 110 USD

Laagste 85 USD

Gebaseerd op 17 Wall Street-analisten die 12-maands prijsdoelen bieden voor Edwards Lifesciences Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

17 ratings

14

Buy

3

Hold

0

Sell

Sentiment

By Acuity

47 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.